Guyer William — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Guyer William has filed 4 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $21.09M.

Profile

Guyer William

William Guyer is the Chief Development Officer at Corcept Therapeutics Inc, a pharmaceutical company focused on developing treatments for disorders related to cortisol. He has been involved in multiple SEC filings related to the company's operations.

RoleInsider
Notability20/100

Board memberships

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-08CORTCORCEPT THERAPEUTICS INCS — Open-market sale952$93.54$89K
2026-07-08CORTCORCEPT THERAPEUTICS INCS — Open-market sale19.0K$93.11$1.77M
2026-07-08CORTCORCEPT THERAPEUTICS INCM — Option exercise20.0K$21.65$433K
2026-06-04CORTCORCEPT THERAPEUTICS INCS — Open-market sale20.0K$70.60$1.41M
2026-06-04CORTCORCEPT THERAPEUTICS INCM — Option exercise20.0K$21.65$433K
2026-06-03CORTCORCEPT THERAPEUTICS INCA — Grant or award877$0.00
2026-06-03CORTCORCEPT THERAPEUTICS INCA — Grant or award877$70.44$62K
2026-05-07CORTCORCEPT THERAPEUTICS INCS — Open-market sale20.0K$51.83$1.04M
2026-05-07CORTCORCEPT THERAPEUTICS INCM — Option exercise20.0K$21.65$433K
2026-04-08CORTCORCEPT THERAPEUTICS INCS — Open-market sale [10b5-1]20.0K$40.97$819K
2026-04-08CORTCORCEPT THERAPEUTICS INCM — Option exercise [10b5-1]20.0K$21.65$433K
2026-03-24CORTCORCEPT THERAPEUTICS INCS — Open-market sale [10b5-1]11.8K$36.01$424K
2026-03-24CORTCORCEPT THERAPEUTICS INCM — Option exercise [10b5-1]11.8K$21.65$255K
2026-03-06CORTCORCEPT THERAPEUTICS INCS — Open-market sale [10b5-1]8.2K$35.99$296K
2026-03-06CORTCORCEPT THERAPEUTICS INCM — Option exercise [10b5-1]8.2K$21.65$178K
2026-03-05CORTCORCEPT THERAPEUTICS INCA — Grant or award498$0.00
2026-03-05CORTCORCEPT THERAPEUTICS INCA — Grant or award498$35.97$18K
2026-02-05CORTCORCEPT THERAPEUTICS INCS — Open-market sale [10b5-1]20.0K$40.87$817K
2026-02-05CORTCORCEPT THERAPEUTICS INCM — Option exercise [10b5-1]20.0K$21.65$433K
2026-01-09CORTCORCEPT THERAPEUTICS INCS — Open-market sale [10b5-1]20.0K$35.18$704K

Companies — Last 90 Days

Frequently Asked Questions

Who is Guyer William?

William Guyer is the Chief Development Officer at Corcept Therapeutics Inc, a pharmaceutical company focused on developing treatments for disorders related to cortisol. He has been involved in multiple SEC filings related to the company's operations.…

How many SEC Form 4 filings has Guyer William submitted recently?

4 primary Form 4 filings in the last 90 days, covering 1 company.

Has Guyer William been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 30 open-market sales ($21.09M) across all tracked filings.

Where can I see all of Guyer William's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Guyer William profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.